Table: Medrx -2024 group results

Medrx

12/03/2025 06:30

Mar 12 (Reuters)- 
          Medrx.Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Dec 31, 2024    Dec 31, 2023    Dec 31, 2025      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales          257 mln         29 mln          122 mln                 
              (+773.3 pct)     (-50.3 pct)     (-52.5 pct)               
  Operating   loss 793 mln    loss 933 mln      loss 1.34                
  Recurring   loss 755 mln    loss 930 mln      loss 1.34                
  Net
  Net         loss 806 mln    loss 932 mln      loss 1.35                
  EPS        loss 18.56 yen  loss 26.82 yen  loss 28.43 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Medrx.Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T